Bigfoot’s goal is to make pump-sensor therapy simpler than the pump companies before them have. They envision themselves as a service provider rather than a hardware or device company. Their service will be to “do a better job delivering insulin,” automating your between-meal insulin therapy, the communication between your pump and your Dexcom CGM, even so far as serving as a single point of contact for all of your supply and prescription inventory management, sending you supplies when you need them, “connecting everything, making it intuitive,” says Brewer. Read more
While we will not see a true artificial pancreas – a closed-loop insulin pump and continuous glucose monitoring system – come to market in 2016, we are so close we can artificially taste it. Read more
The first improvement over Lantus, according to Hobbs, is simply the length of time the insulin lasts. While Lantus lasts up to 24 hours per dose “with no pronounced peak,” Tresiba lasts considerably longer.
I hated the way my pump interfered with my outfits. I hated the middle of the night beeping. And I really hated changing the reservoir. Yet, since I’d been pumping since I was eight years old, by the time I was in my freshman year of college, being on a pump was all I knew. Read more
Researchers at MIT successfully tested an engineered “smart insulin” on mice that reacts to blood sugar levels. “To make insulin that is glucose responsive is something that we believe will significantly improve blood sugar control in people with diabetes,” said … Read more
I was given the opportunity to do a free two-week trial of the Vibe on behalf of A Sweet Life. Having never used an Animas pump before (but nearly all of their competitors), I was particularly excited to see what they’re all about and to get my hands on the first Dexcom G4-integrated pump system. Read more
Will I prescribe Afrezza for people with diabetes? Not a lot, and not for past or present smokers, and not for people with any breathing problems (or heart issues that might cause difficulty breathing), and not without getting pulmonary function testing and explaining all of what I see as potential risks, and not without close follow-up. Read more
We in the diabetes community need to speak out to argue that a. insulin pumps should be removed from competitive bidding and b. that if they remain in the competitive bidding program, CMS must use a different process to determine reimbursement rates, so that cost-saving does not stifle innovation. Read more
Whether you’re used to a slow priming device or a relatively quick one, you’ve never seen one quite as fast as the Asante Snap. As soon as you twist the cartridge cap on, insulin appears at the end of the introducer needle. The innovative cartridge cap that auto-primes the tubing also contains additional occlusion detection rather than relying solely on back pressure like other pumps. Read more
Enter every pumper’s least welcome buddy – the air bubble. Your insulin pump (regardless of make or model) cannot elegantly handle the pressure changes during ascent and descent and is moving air bubbles and insulin into your body without ever recording evidence of it.